Noteworthy Renal Research Progress Highlighted by George Clinical Scientific Leaders During ASN Kidney Week OVERLAND PARK, KS., Nov. 12, 2021 (GLOBE NEWSWIRE) -- New kidney and metabolic research involving George Clinical teams and scientific leaders has received global attention during the 2021 American...

Neuropharmacologist and CRO Veteran Graham Birrell Joins George Clinical to Lead APAC Operations SYDNEY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Graham Birrell, PhD, MBA, a researcher and neuropharmacologist with significant clinical research experience in the EU and Asia-Pacific region has joined...

DARE-19 Phase III Collaboration between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile Was Consistent in Patients with COVID-19 OVERLAND PARK, KS, July 29, 2021 (GLOBE NEWSWIRE) -- The findings of DARE-19, a double-blind, placebo-controlled Phase III trial examining Dapagliflozin in patients with cardiometabolic risk factors...

George Clinical and Omico Align to Evolve Oncology Study Enrollment Through Genomic Profiling in Australia SYDNEY, June 15, 2021 (GLOBE NEWSWIRE) -- George Clinical, a global scientifically-backed clinical research organization, and Omico, an Australian-based not-for-profit national precision oncology...

Link Health and George Clinical Create New Mode of Pharmaceutical Research and Development in China BEIJING and SYDNEY, April 29, 2021 (GLOBE NEWSWIRE) -- Guangzhou Link Health Pharma Co., Ltd. (Link Health) and George Clinical Pty Ltd (George Clinical) have signed a term sheet to enter into a...